These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25479712)

  • 61. Comparative study between 2 protocols for management of severe pain in patients with unresectable pancreatic cancer: one-year follow-up.
    Amr YM; Makharita MY
    Clin J Pain; 2013 Sep; 29(9):807-13. PubMed ID: 23917696
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Breakthrough cancer pain and rational drug use.
    Olarte JM
    Support Care Cancer; 2017 Apr; 25(Suppl 1):11-17. PubMed ID: 28213817
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [[Non-opioid analgesics--irreplaceable in cancer pain therapy?].
    Ladner E; Plattner R; Friesenecker B; Berger J; Javorsky F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Nov; 35(11):677-84. PubMed ID: 11130128
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacological management of cancer pain in the elderly.
    Mercadante S; Arcuri E
    Drugs Aging; 2007; 24(9):761-76. PubMed ID: 17727305
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Pain management in sickle cell disease].
    Rasche T; Emmert D; Seidel H; Sellin J; Conrad R; Mücke M
    Schmerz; 2020 Jun; 34(3):285-296. PubMed ID: 32367470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacological management of pain in Australian Aged Care Facilities.
    Veal FC; Bereznicki LR; Thompson AJ; Peterson GM
    Age Ageing; 2014 Nov; 43(6):851-6. PubMed ID: 24927723
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Management of chronic pain in cancer patients: practical applications].
    Ferri-Dessens RM; Thomas P; Barlési F; Kleisbauer JP
    Rev Mal Respir; 2001 Feb; 18(1):79-85. PubMed ID: 14639184
    [No Abstract]   [Full Text] [Related]  

  • 68. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer. A systematic review of the literature.
    Nabal M; Librada S; Redondo MJ; Pigni A; Brunelli C; Caraceni A
    Palliat Med; 2012 Jun; 26(4):305-12. PubMed ID: 22126843
    [TBL] [Abstract][Full Text] [Related]  

  • 69. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
    Rauck RL
    Pain Pract; 2009; 9(6):468-79. PubMed ID: 19874536
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A modern analgesics pain 'pyramid'.
    Raffa RB; Pergolizzi JV
    J Clin Pharm Ther; 2014 Feb; 39(1):4-6. PubMed ID: 24383938
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The global experience of cancer pain.
    Brant JM
    Asian Pac J Cancer Prev; 2010; 11 Suppl 1():7-12. PubMed ID: 20590341
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Staged analgesic therapy in tumor pain].
    Zenz M; Roth SL; Strumpf M
    Praxis (Bern 1994); 1998 Sep; 87(36):1126-34. PubMed ID: 9782740
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
    Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
    Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Cancer pain management].
    Heigl P
    Orv Hetil; 2014 Jan; 155(3):93-9. PubMed ID: 24412947
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pregabalin vs. opioids for the treatment of neuropathic cancer pain: a prospective, head-to-head, randomized, open-label study.
    Raptis E; Vadalouca A; Stavropoulou E; Argyra E; Melemeni A; Siafaka I
    Pain Pract; 2014 Jan; 14(1):32-42. PubMed ID: 23464813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.
    Mercadante S; Adile C; Cuomo A; Aielli F; Cortegiani A; Casuccio A; Porzio G
    J Pain Symptom Manage; 2015 Nov; 50(5):579-86. PubMed ID: 26303188
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Opioids in cancer-related pain: current situation and outlook.
    George B; Minello C; Allano G; Maindet C; Burnod A; Lemaire A
    Support Care Cancer; 2019 Aug; 27(8):3105-3118. PubMed ID: 31127436
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
    Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
    Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
    [No Abstract]   [Full Text] [Related]  

  • 79. [Cancer pain management. Basic therapy and treatment of breakthrough pain].
    Nauck F; Eulitz N
    Schmerz; 2007 Aug; 21(4):359-70; quiz 371-2. PubMed ID: 17684772
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Opioids for chronic noncancer pain: recommendations based on clinical practice guidelines].
    Català E; Ferrándiz M; Lorente L; Landaluce Z; Genové M
    Rev Esp Anestesiol Reanim; 2011 May; 58(5):283-9. PubMed ID: 21688507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.